| 标题： | 如意珍宝丸临床应用专家共识 |
| title： | The CACM experts consensus for Ruyi Zhenbao pill clinical application |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 治疗 |
| field： | Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 本共识适用于全国各级医院、基层医疗卫生机构临床医师（中医、西医、中西医结合专业），指导临床正确使用如意珍宝丸治疗骨关节炎与缺血性脑卒中。 |
| Guide users： | This consensus is applicable to clinicians (Chinese medicine, western medicine, integrated traditional Chinese and western medicine) in hospitals and primary medical and health institutions at all levels in China, and guides the correct clinical use of Ruyi Zhenbao Pill to treat osteoarthritis and ischemic stroke. |
| 证据分级方法： | 本共识采用国际公认的证据分级推荐标准GRADE系统。专家共识意见的形成采用名义组法，主要考虑六个方面的因素：证据质量、疗效、安全性、经济性、患者可接受性及其他。 |
| Evidence grading method： | This consensus adopts the internationally recognized evidence grading recommendation standard GRADE system. Nominal group method is used to form expert consensus, which mainly considers six factors: evidence quality, curative effect, safety, economy, patient acceptability and others. |
| 制定单位： | 中国中医科学院望京医院、 北京中医药大学东直门医院、中国中医科学院中医临床基础医学研究所、金诃藏药股份有限公司 |
| Formulating unit： | Wangjing Hospital of Chinese Academy of Traditional Chinese Medicine, Dongzhimen Hospital of Beijing University of Chinese Medicine, Institute of Clinical Basic Medicine of Chinese Academy of Traditional Chinese Medicine, Jinhe Tibetan Medicine Co., Ltd. |
| 注册时间： | 2023-02-06 |
| Registration time： | |
| 注册编号： | PREPARE-2023CN063 |
| Registration number： | |
| 指南制订的目的： | 明确如意珍宝丸治疗骨关节炎与缺血性脑卒中的疗效、给药方案与时机、剂量疗程特点、安全性问题等，旨在提高临床疗效，促进合理用药，减少用药风险。 |
| Purpose of the guideline： | To clarify the curative effect, administration scheme and timing, characteristics of dosage and course of treatment, and safety issues of Ruyi Zhenbao Pill in the treatment of osteoarthritis and ischemic stroke, so as to improve the clinical efficacy, promote rational drug use and reduce the risk of drug use. |
